GeneChem

The therapeutic potential of human milk oligosaccharide (HMO) sialyllactose has fascinated researchers for decades. After attracting attention in the 1980s, a new set of scientists to revitalize the sector by studying the effect of synthesized sialyllactose in osteoarthritis (OA) and other indications. 

https://www.nutraingredients.com/News/Promotional-Features/Positioning-sialyllactose-to-unlock-the-joint-health-market